XML 28 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Debt
3 Months Ended
Mar. 31, 2017
Debt [Abstract]  
Debt

Note 10 – Debt



The Company’s borrowings at March 31, 2017 and December 31, 2016, net of deferred financing costs and including the impact of interest rate derivatives on effective interest rates, are summarized below:





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

As of March 31, 2017

(Dollars in thousands)

 

Maturity Date

 

Contractual Facility

 

Balance, Gross

 

Balance, Net(3)

 

Stated Interest Rate

 

Effective Interest Rate (1)

Denominated in USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Trust Preferred Securities (USA)

 

April 30, 2027

 

$

27,913 

 

$

27,913 

 

$

27,393 

 

5.04%

 

5.20%



Bank of America Credit Facility (USA)

 

November 28, 2019

 

 

55,000 

 

 

39,000 

 

 

38,866 

 

3.48%

 

3.65%



Bank of America Line of Credit (USA)

 

October 31, 2019

 

 

5,000 

 

 

1,000 

 

 

1,000 

 

3.98%

 

3.98%



Cinema 1, 2, 3 Term Loan (USA)

 

September 1, 2019

 

 

19,800 

 

 

19,800 

 

 

19,293 

 

3.25%

 

3.25%



Minetta & Orpheum Theatres Loan (USA)

 

June 1, 2018

 

 

7,500 

 

 

7,500 

 

 

7,416 

 

3.56%

 

3.56%



U.S. Corporate Office Term Loan (USA)

 

January 1, 2027

 

 

8,333 

 

 

8,333 

 

 

8,212 

 

4.64%

 

4.64%



Union Square Construction Financing (USA)

 

December 29, 2019

 

 

57,500 

 

 

8,000 

 

 

4,942 

 

5.24%

 

5.24%

Denominated in foreign currency ("FC") (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



NAB Corporate Term Loan (AU)

 

June 28, 2019

 

 

50,793 

 

 

31,316 

 

 

31,185 

 

2.63%

 

2.63%



Westpac Corporate Credit Facility (NZ)

 

December 31, 2018

 

 

37,105 

 

 

10,502 

 

 

10,502 

 

3.70%

 

3.70%



 

$

268,944 

 

 

153,364 

 

 

148,809 

 

 

 

 





(1) Effective interest rate includes the impact of interest rate derivatives hedging the interest rate risk associated with Trust Preferred Securities and Bank of America Credit Facility that were outstanding as of March 31, 2017.

(2) The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of March 31, 2017.

(3) Net of deferred financing costs amounting to $4.6 million.

(4) The loan for our Minetta & Orpheum Theatres was obtained from Santander Bank. The term loan for our Cinema 1,2,3 Theatre was refinanced during the third quarter of 2016 with Valley National Bank. The term loan, which is collateralized by our new U.S Corporate Headquarters office building, was obtained with Citizens Asset Finance, Inc. during the fourth quarter of 2016.  In December 2016, we successfully negotiated the construction financing for our Union Square redevelopment project, $8.0 million of which was advanced from the total construction loan limit of $57.5 million





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

As of December 31, 2016

(Dollars in thousands)

 

Maturity Date

 

Contractual Facility

 

Balance, Gross

 

Balance, Net(3)

 

Stated Interest Rate

 

Effective Interest Rate (1)

Denominated in USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Trust Preferred Securities (USA)

 

April 30, 2027

 

$

27,913 

 

$

27,913 

 

$

27,340 

 

4.89%

 

5.20%



Bank of America Credit Facility (USA)

 

November 28, 2019

 

 

55,000 

 

 

39,950 

 

 

39,759 

 

3.27%

 

3.90%



Bank of America Line of Credit (USA)

 

October 31, 2019

 

 

5,000 

 

 

--

 

 

--

 

3.77%

 

3.77%



Cinema 1, 2, 3 Term Loan (USA)(4)

 

September 1, 2019

 

 

19,901 

 

 

19,901 

 

 

19,356 

 

3.25%

 

3.25%



Minetta & Orpheum Theatres Loan (USA)(4)

 

June 1, 2018

 

 

7,500 

 

 

7,500 

 

 

7,398 

 

3.38%

 

3.38%



U.S. Corporate Office Term Loan (USA)(4)

 

January 1, 2027

 

 

8,363 

 

 

8,363 

 

 

8,239 

 

4.64%

 

4.64%



Union Square Construction Financing (USA)(4)

 

December 29, 2019

 

 

57,500 

 

 

8,000 

 

 

4,751 

 

4.52%

 

4.52%

Denominated in FC (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



NAB Corporate Term Loan (AU)

 

June 30, 2019

 

 

48,080 

 

 

28,558 

 

 

28,421 

 

2.64%

 

2.64%



Westpac Corporate Credit Facility (NZ)

 

March 31, 2018

 

 

36,877 

 

 

8,350 

 

 

8,350 

 

3.80%

 

3.80%



 

 

 

 

$

266,134 

 

$

148,535 

 

$

143,614 

 

 

 

 



(1) Effective interest rate includes the impact of interest rate derivatives hedging the interest rate risk associated with Trust Preferred Securities and Bank of America Credit Facility that were outstanding as of December 31, 2016.

(2) The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2016.

(3) Net of deferred financing costs amounting to $4.9 million.

(4) The loan for our Minetta & Orpheum Theatres was obtained from Santander Bank. The term loan for our Cinema 1,2,3 Theatre was refinanced during the third quarter of 2016 with Valley National Bank. The term loan, which is collateralized by our new U.S Corporate Headquarters office building, was obtained with Citizens Asset Finance, Inc. during the fourth quarter of 2016.  In December 2016, we successfully negotiated the construction financing for our Union Square redevelopment project, $8.0 million of which was advanced from the total construction loan limit of $57.5 million



Union Square Construction Financing

On December 29, 2016, we closed our new construction finance facilities totaling $57.5 million to fund the non-equity portion of the anticipated construction costs of the redevelopment of our property at 44 Union Square in New York City. The combined facilities consist of $50 million in aggregate loans (comprised of three loan tranches) from Bank of the Ozarks (“BOTO”), and a $7.5 million mezzanine loan from Tammany Mezz Investor, LLC, an affiliate of Fisher Brothers.  As of December 31, 2016, BOTO advanced $8.0 million to repay the existing $8.0 million loan with East West Bank.

Presented in the table below is the breakdown of the Union Square construction financing as of March 31, 2017:





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

 

 

Facility Limits and Advances

 

 

 

 

Financing Component

 

Lender

 

Facility Limit

 

Advanced-to- Date

 

Remaining Facility

 

Interest Rate(1)

 

Maturity Date(2)

Mezzanine loan

 

Tammany Mezz Investor LLC

 

$

7,500 

 

$

--

 

$

7,500 

 

Greater of (i) 10.50% and (ii) Adjusted LIBOR + 10%

 

December 29, 2019

Senior loan

 

Bank of the Ozarks

 

 

8,000 

 

 

8,000 

 

 

--

 

Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%

 

December 29, 2019

Building loan

 

Bank of the Ozarks

 

 

31,130 

 

 

--

 

 

31,130 

 

Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%

 

December 29, 2019

Project loan

 

Bank of the Ozarks

 

 

10,870 

 

 

--

 

 

10,870 

 

Greater of (i) 4.75% and (ii) Adjusted LIBOR + 4.25%

 

December 29, 2019

Total Union Square Financing

 

 

 

$

57,500 

 

$

8,000 

 

$

49,500 

 

 

 

 



(1) Not to exceed the New York State maximum lawful borrowing rate, which typically is 16%.

(2) Allowable for up to two (2) extension request options, one (1) year for each extension request.



Cinema 1,2,3 Term Loan

On August 31, 2016, Sutton Hill Properties LLC (“SHP”), a 75% subsidiary of RDI, refinanced its $15 million Santander Bank term loan with a different lender, Valley National Bank.  This new $20 million loan is collateralized by our Cinema 1,2,3 property and bears an interest rate of 3.25% per annum, with principal installments and accruing interest paid monthly. The new loan matures on September 1, 2019, with a one-time option to extend maturity date for another year.



Bank of America Credit Facility

On March 3, 2016, we amended our $55.0 million credit facility with Bank of America to permit real property acquisition loans.  This amendment was subject to the provision that the consolidated leverage ratio would be reduced by 0.25% from the established levels in the credit facility during the period of such borrowing subject further to a repayment of such borrowings on the earlier of the eighteen months from the date of such borrowing or the maturity date of the credit agreement.  Such modification was not considered substantial in accordance with U.S. GAAP.